Tempus, a company founded by Eric Lefkofsky, recently made the decision to partner up with Feist-Weiller Cancer Center to research ways to better aid patients who have brain cancer. Tempus focuses on analyzing RNA and DNA data, which helps physicians to better understand how to treat individuals with cancer. The company has been able to put together a large amount of molecular and clinical data and is moving into the future with the help of artificial intelligence. It is Lefkofsky’s hope that people who suffer from cancer will be able to live happier lives because of the work his company is doing.
Maria-Magdalena Georgescu will be working with Tempus by sharing what she knows about glioblastoma. Tempus will be taking care of the genomic sequencing for the patients of Dr. Georgescu, and the data will be housed at the Feist-Weiller Cancer Center in Shreveport. Eric Lefkofsky will be overseeing the work of his company, which will be analyzing the data to see if any patterns can be found. Glioblastoma grows quickly and takes over healthy parts of the brain extremely fast. It is hard to treat because of how fast it spreads, and most people only live for a year and a few months once they have been diagnosed.
Eric Lefkofsky is more than happy to be able to help fight cancer and continues to find new ways of using his company Tempus to do so. The company is able to offer many tools and modern technologies that are making it easier for doctors to better understand their patients’ cancer. One of the best offerings from Tempus is data that helps physicians to know what specific kinds of cancers have responded well to in the past. The company is expecting to continue to build new partnerships and plans on continuing to work with LSU Health Shreveport, Feist-Weiller Cancer Center, and Dr. Georgescu.
Eric Lefkofsky is the CEO of Tempus and the founder of Lightbank. He studied at the University of Michigan and earned his J.D. at the university’s law school. As the co-founder of the Lefkofsky Family Foundation, he has done a lot of good in Chicago by supporting the arts, culture, and the health sector.